Abstract
Pancreatic cancer will become the second leading cause of cancer-related death in the United States by 2030. Survival improves when it is identified at an early-stage and resected. Increasing public attention and cross-section imaging may shift detection to earlier stages. We found a small total increase in the proportion of stage-I cancer relative to all stages and a significant increase compared to distant disease in the Surveillance, Epidemiology, and End Results (SEER) database. Despite this, our ability to screen and identify early-stage disease is still lacking. Additional research and population-based interventions are necessary to improve early detection.
Original language | English (US) |
---|---|
Pages (from-to) | 229-234 |
Number of pages | 6 |
Journal | Cancer Investigation |
Volume | 39 |
Issue number | 3 |
DOIs | |
State | Published - 2021 |
Keywords
- Pancreatic neoplasms
- digestive system neoplasms
- epidemiology
- pancreas
- public health
ASJC Scopus subject areas
- Oncology
- Cancer Research